Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02KBD
|
||||
| Drug Name |
Mebutamate
|
||||
| Synonyms |
Dormate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Anxiolytic and sedative [ICD10:F40-F42] | Approved | [1] | ||
| Company |
Medpointe Pharmaceuticals Medpointe Healthcare Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C10H20N2O4
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | GABA A receptor | Target Info | Modulator | [2] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Retrograde endocannabinoid signaling | |||||
| GABAergic synapse | |||||
| Morphine addiction | |||||
| Nicotine addiction | |||||
| Reactome | Ligand-gated ion channel transport | ||||
| GABA A receptor activation | |||||
| WikiPathways | SIDS Susceptibility Pathways | ||||
| Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | |||||
| Iron uptake and transport | |||||
| References | |||||
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.